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Summary 
Background Community-based active case-finding interventions might identify and treat more people with tuberculosis 
disease than standard case detection. We aimed to assess whether active case-finding interventions can affect 
tuberculosis epidemiology in the wider community.
Methods We did a systematic review by searching PubMed, Embase, Scopus, and Cochrane Library for studies that 
compared tuberculosis case notification rates, tuberculosis disease prevalence, or tuberculosis infection prevalence or 
incidence in children, between populations exposed and unexposed to active case-finding interventions. We included 
studies published in English between Jan 1, 1980, and April 13, 2020. Studies of active case-finding in the general 
population, in populations perceived to be at high risk for tuberculosis, and in closed settings were included, whereas 
studies of tuberculosis screening at health-care facilities, among household contacts, or among children only, and 
studies that screened fewer than 1000 people were excluded. To estimate effectiveness, we extracted or calculated case 
notification rates, prevalence of tuberculosis disease, and incidence or prevalence of tuberculosis infection in children, 
and compared ratios of these outcomes between groups that were exposed or not exposed to active case-finding 
interventions.
Results 27 883 abstracts were screened and 988 articles underwent full text review. 28 studies contributed data for 
analysis of tuberculosis case notifications, nine for prevalence of tuberculosis disease, and two for incidence or 
prevalence of tuberculosis infection in children. In one cluster-randomised trial in South Africa and Zambia, an 
active case-finding intervention based on community mobilisation and sputum drop-off did not affect tuberculosis 
prevalence, whereas, in a cluster-randomised trial in Vietnam, an active case-finding intervention based on sputum 
tuberculosis tests for everyone reduced tuberculosis prevalence in the community. We found inconsistent, low-quality 
evidence that active case-finding might increase the number of cases of tuberculosis notified in populations with 
structural risk factors for tuberculosis.
Interpretation Community-based active case-finding for tuberculosis might be effective in changing tuberculosis 
epidemiology and thereby improving population health if delivered with high coverage and intensity. If possible, 
active case-finding projects should incorporate a well designed, robust evaluation to contribute to the evidence base 
and help elucidate which delivery methods and diagnostic strategies are most effective.
Funding WHO Global TB Programme.
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 
license.
Introduction 
Tuberculosis is the leading infectious cause of death 
worldwide.1 An estimated 3 million people with active 
tuberculosis were either not diagnosed or were diagnosed 
but not notified through national reporting systems 
in 2019.1 The so-called missing millions of people with 
undiagnosed or untreated active tuberculosis are at risk of 
death and severe illness, and can transmit tuberculosis to 
others in their households and communities. Declines in 
global tuberculosis incidence have been slow and, at the 
rate of current progress, are unlikely to meet the WHO 
End TB Strategy targets to reduce incidence by 90% 
and tuberculosis deaths by 95% by 2035. Therefore, imple-
mentation of effective, evidence-based strategies that 
can increase diagnosis and treatment of tuberculosis, 
and potentially reduce tuberculosis transmission, are 
urgently required.
Community-based tuberculosis screening, delivered 
through active case-finding interventions, has been widely 
implemented throughout the 20th and 21st centuries, but 
with varying levels of intensity between regions and 
over time. Because tuberculosis care and prevention 
interventions that rely primarily on passive case detection 
and health facility-based screening strategies have insuffi-
ciently reduced tuberculosis incidence, many national 
tuberculosis programmes have promoted community-
based active case-finding interventions.2
Active case-finding encompasses a wide range of acti-
vities that range in intensity from health promotion cam-
paigns and community mobilisation, through to systematic 
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identification and offering screening and diag nosis 
to entire populations. Generally, active case-finding aims to 
diagnose tuberculosis either in those who do not recognise 
that they have symptoms, or those who do recognise 
symptoms but for whatever reason do not, or cannot, 
access services at health-care facilities.2,3 We expect that an 
effective community-based active case-finding intervention 
would initially increase the number of people diagnosed 
with tuberculosis and started on tuberculosis treatment 
(ie, increase case notifications) in a given set ting. When 
this occurs, tuberculosis transmission might decline 
because people are diagnosed earlier in their disease 
course, potentially reducing the length of time in which 
an individual is infectious to others.4,5 If tuberculo-
sis active case-finding is successful, we would expect to 
see a reduction in tuberculosis disease prevalence and 
in prevalence and incidence of tuberculosis infection 
in children.
Despite widespread implementation of active case-
finding interventions globally, the evidence for effectiveness 
and the optimal approaches to delivering active case-
finding interventions remain uncertain. There fore, we 
aimed to systematically appraise evidence for the effective-
ness of active case-finding interventions on tuberculosis 
case notifications, tuberculosis disease prevalence, and 
tuberculosis infection incidence and prevalence.
Methods 
Search strategy and selection criteria 
We systematically reviewed the literature for studies that 
reported the effects of active case-finding interventions on 
tuberculosis epidemiological indicators. Our literature 
search was an update of a 2013 systematic review by 
Kranzer and colleagues,3 which covered the period between 
Jan 1, 1980, and Oct 13, 2010, with additional searches by 
that group up to the end of 2011. We did a systematic 
search of PubMed, Embase, Scopus, and Cochrane Library 
for papers published between Nov 1, 2010, and Feb 14, 2019 
(subsequently updated to April 13, 2020). The search terms 
used are described in the appendix (pp 15–16).
We included studies that evaluated at least one active 
case-finding intervention and contained data to permit 
a comparison of tuberculosis epidemiology between 
populations exposed and not exposed to active case-finding 
(or populations exposed to two different methods of active 
case-finding). Eligible study designs included randomised 
controlled trials, non-randomised parallel group studies 
with outcome measurement before and during the 
intervention period (referred to as controlled before-after 
studies), and studies that compared outcomes before and 
after the intervention period in the same population 
(referred to as before-after studies). Because the epi-
demiology of tuberculosis differs substantially between 
children and adults, we excluded studies that were 
done only among children (aged <15 years). Studies must 
have screened at least 1000 people for tuberculosis 
because the prevalence of tuberculosis disease will rarely 
exceed 1% in any given community. If tuberculosis 
screen ing was targeted at a subset of a population but 
effects were measured in the wider population, the 
target population must have comprised at least 10% of 
the whole population. We excluded studies that were 
published before Jan 1, 1980, and studies not published 
in English.
We reviewed the full text of studies included in the 
systematic review by Kranzer and colleagues,3 as well as 
Research in context
Evidence before this study
Active case-finding for tuberculosis is one of the longest 
running and most widely implemented screening interventions. 
We did preliminary scoping review searches in PubMed and 
MEDLINE in February, 2019, using medical subject headings, 
keyword, and title word search terms including “tuberculosis”, 
“mass screening”, and “case finding”. We also sought expert 
opinion (in sessions convened to facilitate the 2020 WHO 
tuberculosis screening guideline development process) to 
identify studies related to active case-finding for tuberculosis. 
We identified a systematic review from 2013 on the individual-
level and community-level effects of tuberculosis active 
case-finding, which covered literature published up until 
December, 2011. The review concluded that the benefits of 
active case-finding for tuberculosis disease remained uncertain.
Added value of this study
Since the previous systematic review published in 2013, several 
large randomised and non-randomised studies evaluating the 
effectiveness of community-based active case-finding for 
tuberculosis have been published. Our systematic review 
synthesises this new evidence and includes data from 
36 studies from 16 countries, comprising at least 
110 million person-years of follow-up in studies done 
between 1980 and 2020. With new evidence from two large 
cluster-randomised trials done in South Africa and Zambia and 
in Vietnam that were not included in the previous systematic 
review, we found moderate quality evidence from some of the 
reviewed studies that active case-finding, when implemented 
with sufficient coverage and intensity in high-prevalence 
settings, can positively affect the community epidemiology 
of tuberculosis.
Implications of all the available evidence
Health planners and national tuberculosis programmes should 
consider the implementation of active case-finding for 
tuberculosis interventions as part of well designed research 
protocols in urban populations with a high prevalence of 
undiagnosed tuberculosis and in other populations, 
to contribute evidence to outstanding knowledge gaps.
See Online for appendix
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those meeting eligibility criteria at title and abstract 
screen of the updated search. Each full text was reviewed 
by two of RMB, MN, and HRAF, and discrepancies were 
resolved by consensus discussion with ELC and PM. 
Reference lists from the included studies were examined 
and expert opinion on other available studies was sought 
from members of the WHO TB Screening Guideline 
Development Group.
Data analysis 
Data were extracted from the studies independently in 
duplicate (by two of RMB, MN, and HRAF) into a case 
record form; discrepancies were resolved by discussion 
and data were entered into a spreadsheet.
Outcomes were comparisons between intervention and 
control groups of tuberculosis case notification rates per 
100 000 population, prevalence of pulmonary tuberculosis 
disease (measured during a population prevalence survey 
following the active case-finding intervention period), 
and incidence or prevalence of tuberculosis infection in 
children (measured by tuberculin skin test or interferon 
γ assay surveys). For tuberculosis case notification rates, 
we used the number of people who started tuberculosis 
treatment as the numerator; however, if studies reported 
only numbers diagnosed with tuberculosis, we included 
this as a proxy for case notifications.
To investigate the effects of active case-finding on 
tuberculosis case notification rates, if possible, we extracted 
or calculated person-years of follow-up and numbers of 
tuberculosis cases notified in each group. We used simple 
arithmetic to estimate person-years of follow-up if this 
was not directly reported. For randomised studies and 
before-after studies, case notification rate ratios (in 
intervention vs control populations or baseline vs endline 
popula tions) were calculated. For studies that had a 
non-randomised comparator and compared tuberculosis 
case notification rate trends over time in two groups 
(controlled before-after studies) we calculated the differ-
ence between case notification rate ratios in the groups 
with and without exposure to active case-finding. We 
additionally reported the authors’ effect estimates (or 
measures of association) and CIs, if provided, and summar-
ised any statistical adjustments for clustering and con-
founding. We did not calculate CIs from available grouped 
summary data because this would require adjustment for 
effects of clustering and confounders, neither of which 
were typically reported.
For studies that reported effects of active case-finding 
on tuberculosis prevalence we extracted the size of 
intervention population, number of people screened for 
tuberculosis during active case-finding, method of tuber-
culosis screening, number of people in the prevalence 
survey or surveys, definition of a tuberculosis case, and 
numbers of people with tuberculosis disease. We reported 
summary measures of the effect of active case-finding on 
tuberculosis prevalence and uncertainty intervals as 
reported within the studies.
Active case-finding was defined as interventions imple-
mented in a community that endeavoured to systematically 
screen people for tuberculosis. A tuberculosis screen 
could take any form but required a personal interaction 
between a screener and the person being screened (eg, 
leaflet distribution alone would not meet this definition). 
The following interventions are examples of active 
case-finding: mobile tuberculosis screening or diagnostic 
clinics or sputum drop off points; mobilisation and 
training of community health workers and volunteers as 
screeners to detect tuberculosis symptoms and potentially 
do tuberculosis diagnostic tests in community members; 
door-to-door tuberculosis screening with symptom inter-
view, sputum collection, or both. We included tuberculosis 
screening in closed community settings (eg, prisons) or 
occupational groups (eg, among miners). Tuberculosis 
screening interventions delivered at permanent health 
facilities and for contacts of people with tuberculosis 
did not constitute active case-finding interventions for 
this review.
Figure 1: Study selection
10 articles (9 studies) included in 
qualitative synthesis of tuberculosis 
prevalence and infection
978 articles excluded from analysis of 
tuberculosis prevalence and 
infection
 813 no comparison group      
 47 health-care-based screening
 32 no relevant data  
 32 reported case notifications 
only
 22 fewer than 1000 people 
screened   
 18 active case-finding in 
children only 
 8 contact tracing   
 3 duplicate paper 
 3 study published before 1980  
27 883 potentially eligible articles identified 
by database searches (with duplicates 
removed)
 23 466 in search from Nov 1, 2010, 
                              to Feb 14, 2019
 4417 in search from Feb 1, 2019, 
                              to April 13, 2020 
988 articles included in full text screening
26 962 articles not eligible for inclusion
67 additional articles identified
 60 in systematic review by 
             Kranzer and colleagues3
 7 in reference list searches
30 articles (28 studies) included in 
qualitative synthesis of tuberculosis 
case notification rates
958 articles excluded from analysis of 
tuberculosis case notification 
rates
 813 no comparison group      
 47 health-care-based screening
 32 no relevant data
 22 fewer than 1000 people 
screened   
 18 active case-finding in 
children only 
 9 reported prevalence only
 8 contact tracing 
 6 duplicate paper
 3 study published before 1980  
Articles





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































10 www.thelancet.com/public-health   Published online March 22, 2021   https://doi.org/10.1016/S2468-2667(21)00033-5
We classified studies according to the population groups 
they targeted, including general populations, remote rural 
populations, people living in informal urban settlements, 
people in prison, people experiencing homelessness, 
refugees or displaced people, and indigenous populations. 
Active case-finding interventions were often delivered 
concurrently alongside a wider set of tuberculosis screen-
ing and care activities (co-interventions, such as facility-
based screening or laboratory strengthening). We recorded 
the presence of co-interventions.
To assess risk of bias, we used Cochrane RoB 2 for ran-
domised trials6 and the ROBINS-i tool for non-randomised 
studies.7 Quality assessment was done collab oratively by 
two authors (RMB and PM). Because we did not do a 
meta-analysis, we did not stratify assessments on the basis 
of study quality.
Role of the funding source 
WHO facilitated discussions among authors at the design 
stage but had no role in data collection, data analysis, data 
interpretation, or writing of the report.
Results 
The literature search from Nov 1, 2010, to Feb 14, 2019, 
returned 23 466 unduplicated titles and abstracts; the 
updated search on April 13, 2020, identified a further 
4417 titles and abstracts. 921 articles from these searches 
were identified for full text review. An additional 67 articles 
were identified from the systematic review by Kranzer and 
colleagues3 (published from Jan 1, 1980, to Dec 31, 2011) 
and from searching reference lists, resulting in a total of 
988 articles that underwent full text review (figure 1). A 
total of 36 studies were included in our systematic review.
We identified 30 articles reporting 28 studies on the 
effects of active case-finding interventions on tuberculosis 
case notification rates (tables 1–3; appendix pp 2–7). These 
studies included six cluster-randomised trials (two of 
which compared two active case-finding interventions to 
each other), 13 con trolled before-after studies, and nine 
before-after studies. One of the cluster-randomised trials, 
which compared two strategies to each other,11 was also 
included as a before-after study.
Of the 28 studies, five were done in general popu-
lations,11,16–18,25 seven were done in high-density, low-income 
urban areas,10,19,23,26–28,32 two were done in camps for internally 
displaced people,20,21 four were done in remote rural popu-
lations,8,9,22,35 four were done among indigenous populations 
(two of which were also in high-density, low-income urban 
areas),19,24,26,29 four were done in prisons,13,30,33,34 one was 
done in gold mines,12 and two were done among people 
experiencing homelessness.14,15
Several types of active case-finding intervention were 
used and some studies used more than one (tables 1–3, 
appendix pp 2–7). The active case-finding interventions 
included door-to-door screening (14 studies);10,11,17,19–26,28,32,34 
sputum collection by community health workers or volun-
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combined with mobile tuberculosis screen ing clinics 
(six studies).11,18,20,27,29,35 17 studies included co-interventions 
that could affect tuberculosis detection in the community, 
including financial incentives for tuberculosis detec-
tion;16,23,24,26,27 facility-based tuberculosis screening;20,21,34 
laboratory or health facility upgrading;21,22,28,30 household 
contact tracing;20–23,32,34 and latent tuberculosis infection 
treatment.14,17,22
Most studies (21 of 28) used tuberculosis symptom 
screening as the first step in the screening algorithm. Five 
studies used chest x-ray regardless of symptoms.12,25,30,31,35 
Three studies used a tuberculin skin test as the first 
screening test.14,17,31 In one study, chest x-ray was used to 
screen people for tuberculosis, but sputum was addi-
tionally collected regardless of symptoms or chest x-ray 
findings.30
Four randomised trials assessed the effect of active case-
finding on tuberculosis case notifications compared with 
no active case-finding.8–10,13 Two trials showed an increase 
in tuberculosis case notifications,9,13 whereas the other 
two trials did not show effectiveness (table 1, figure 2).8,10
In non-randomised studies, populations who received 
active case-finding interventions consistently had higher 
tuberculosis case notification rates than comparison 
populations, with the highest case notification rate ratios 
in prisons, remote rural communities, and indigenous 
populations (figure 2). There was considerable variation in 
comparison and measurement periods. For the random-
ised trials, risk of bias was assessed as low (four studies) or 
as having some concerns (two studies; appendix p 14). The 
majority of non-randomised studies had a severe 
(ten studies) or critical (nine studies) risk of bias.
Two cluster-randomised trials compared the effects 
of active case-finding versus no active case-finding on 
tuberculosis prevalence in general populations (table 4).36,37 
One further cluster-randomised trial allocated urban 
clusters in Zimbabwe to one of two types of active 
case-finding, and also evaluated change in tuberculosis 
prevalence before and after implementation of active 
case-finding, a non-randomised comparison.11 Six other 
non-randomised studies investigated the effect of active 
case-finding on tuberculosis prevalence in a variety of 
populations (table 5).38–43
The ZAMSTAR study was a cluster-randomised trial in 
24 communities in Zambia and South Africa.36 The active 
case-finding intervention (referred to as enhanced case-
finding) included community mobilisation, educa tion 
about tuberculosis in schools, fast-track sputum collection 
points in health-care facilities, and mobile community 
sputum collection points. Tuberculosis diag nosis in the 
active case-finding intervention was based on smear 
micro scopy. In a post-intervention survey, the overall 
prevalence of culture-positive tuberculosis among those 
with valid sputum samples (with 90% survey participation, 
73% sputum collection, and approximately two-thirds with 
an evaluable sputum sample) was 1277 per 100 000 people 
in areas without active case-finding (505 people with 
Figure 2: Effect of 
tuberculosis active 
case-finding on tuberculosis 
CNR ratios
(A) Ratio of number of cases of 
tuberculosis disease notified 
per 100 000 person-years in 
intervention clusters vs control 
clusters. (B) Ratio of number 
of cases of tuberculosis disease 
(intervention clusters vs 
non-randomly assigned 
control clusters) notified in 
endline time period vs baseline 
time period. (C) Ratio of 
number of cases of 
tuberculosis disease notified in 
endline time period vs baseline 
time period. CNR=case 
notification rate. *Compared 
two active case-finding 
interventions to each other. 
†Ratio not estimable.
Corbett et al (2010), Zimbabwe
Degner et al (2016), USA*
Fatima et al (2014), Pakistan
Fatima et al (2016), Pakistan
Ford et al (2019), India
John et al (2015), Nigeria
Karamagi et al (2018), Uganda
Lorent et al (2014), Cambodia
Maggard et al (2015), Zambia
Mallick et al (2017), India
Aye et al (2018), Myanmar
Cegielski et al (2010), USA†
Chen et al (2019), China
Datiko et al (2017), Ethiopia
de Vries et al (2007), Netherlands
Delva et al (2017), Haiti
Kan et al (2012), China
Parija et al (2014), India
Reddy et al (2015), India
Rendleman (1999), USA
Sanaie et al (2016), Afghanistan
Shewade et al (2019), India
Vyas et al (2018), India
Adane et al (2019), Ethiopia
Churchyard et al (2011), South Africa*
Corbett et al (2010), Zimbabwe*
Datiko et al (2009), Ethiopia
Miller et al (2010), Brazil
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tuberculosis disease) and 1485 in areas with active 
case-finding (389 people with tuberculosis disease, 
adjusted mean tuberculosis prevalence ratio of 1·09, 
95% CI 0·86–1·40). Among schoolchildren serially tested 
with tuberculin skin test before and after the intervention 
period, positivity among children who had been tuberculin 
skin test negative at baseline was 1·41 per 100 person-years 
in active case-finding clusters (391 children with incident 
tuberculosis infection) and 1·05 in non-active case-finding 
clusters (342 children with incident tuberculosis infection, 
adjusted rate ratio 1·36, 95% CI 0·59–3·14).
In the ACT3 study,37 Marks and colleagues evaluated an 
active case-finding intervention in Vietnam that involved 
3 years of annual household tuberculosis screening using 
sputum Xpert MTB/Rif assays for all people aged 15 years 
or older, regardless of symptoms, in 120 communities. A 
tuberculosis prevalence survey was done in the fourth 
year, with the denominator for the primary outcome being 
the total number of people who consented to be in 
the survey, regardless of sputum production (sputum 
obtained in 33·2% in the intervention group and 40·7% in 
the control group). In the active case-finding interven-
tion group, the prevalence of tuberculosis (one sputum 
sample positive by Xpert) was 126 per 100 000 people 
(53 people with tuberculosis disease) and 226 per 100 000 
(94 people with tuberculosis disease) in the control group 
(adjusted prevalence ratio of 0·56, 95% CI 0·40–0·78). 
A pre specified secondary outcome was prevalence of 
positive QuantiFERON tests among children born in 2012 
(who would have been aged 1–2 years when the inter-
vention started in 2014), as a proxy of incidence of 
tuberculosis infection. Among children born in 2012, 
1409 children had QuantiFERON tests; 23 (3·3%) of 
701 were positive among children in the intervention 
group and 18 (2·6%) of 705 were positive among children 
in the control group (prevalence ratio 1·29, 95% CI, 
0·70–2·36; table 6).
In the DETECTB study in Harare, Zimbabwe,11 the 
prevalence of culture-positive tuberculosis among a 
random sample of 12% of households in each of 46 clusters 
(23 allocated to mobile van active case-finding and 23 to 
door-to-door screening with symptoms and smear) before 
the active case-finding intervention was compared with 
prevalence after five rounds of active case-finding. The 
adjusted risk ratio for tuberculosis disease after active 
case-finding versus before active case-finding was 0·59 
(95% CI 0·40–0·89). A further six non-randomised 
studies were identified from India,39–41 China,41 Brazil,38 
and Ethiopia;42 three were done in the general popu-





Diagnostic method Co-interventions Clusters Tuberculosis cases among people 
screened at sequential 
prevalence surveys, n/N (cases 
per 100 000 population)




Brazil, people in 
prison
Door to door 
and at prison 
entry
Chest x-ray for all, sputum 
smear and culture if chest 
x-ray abnormal
None 1 Baseline, 83/1374 (6040); 
endline, 32/1244 (2800)
Authors report p<0·001 for 




India, remote rural Door to door Chest x-ray for all, sputum 
culture if chest x-ray 
abnormal
Change to NTP 
guidelines in area 
(DOTS introduced)
53 1999–2001, 457/83 425 (607); 
2001–03, 344/85 474 (454); 
2004–06, 253/89 413 (309); 
2006–08, 332/92 255 (388)
Significant decrease in culture-
positive tuberculosis prevalence at 
years 2·5, 5·0, and 7·5; regression 
analysis showed that a linear 
model was inadequate to explain 





India, remote rural Door to door Chest x-ray and sputum 
for culture if symptoms
Change to NTP 
guidelines in area 
(DOTS introduced)
5 June, 1999, to April, 2000, 
25/5096 (490·6); 
year 2·5, 9/4042 (222·7); 
year 5, 3/3978 (75·24); 
year 7·5, 7/3712 (188·6)
No measure of association 
reported




Door to door Chest x-ray if symptoms 
or in high-risk group; 
sputum smear if 
symptoms or abnormal 
chest x-ray
None 3 2013, 35/92 822 (37·7); 
2014, 25/92 638 (27·0); 
2015, 15/89 799 (16·7)*
Site A, 2013 vs 2015, p<0·001; 
site B, 2013 vs 2015, p=0·064; 
site C, 2013 vs 2015, p=0·20
Tsegaye 
Sahle et al 
(2019)42





Sputum tests if symptoms 
(mainly smear, but some 
Xpert and culture); chest 
x-ray available if 
symptoms
None 1 Baseline, 3/3024 (99·2); 
endline, 10/2551 (392)
Prevalence increased from 0·10% 
in the first screening to 0·39% in 
the second screening (p=0·027)




Door to door Sputum smear and culture 
if symptoms
None 53 Baseline, 293/9756 (3003); 
endline, 195/9775 (1995)
Prevalence had decreased 
significantly at endline compared 
with baseline (trend χ² 19·97, 
odds ratio 1·521, p=0·000)
NTP=national tuberculosis programme. DOTS=directly observed therapy, short course. *The prevalence of tuberculosis in each year was averaged across sites A–C.
Table 5: Non-randomised studies evaluating effect of active case-finding on tuberculosis prevalence
Articles
14 www.thelancet.com/public-health   Published online March 22, 2021   https://doi.org/10.1016/S2468-2667(21)00033-5
factors for tuberculosis (two in prisons38,42 and one in 
an indigenous community43). The reported estimates of 
effects on tuberculosis prevalence were mixed (table 5).
The two cluster-randomised trials comparing effects of 
active case-finding on tuberculosis prevalence and tuber-
culosis infection incidence (ZAMSTAR and ACT3)36,37 
both had some concerns of bias relating to participation in 
endline tuberculosis prevalence surveys and completeness 
of outcome sputum evaluation (appendix p 14). The risk of 
bias for DETECTB (before-after comparison) was assessed 
to be serious; the six other non-randomised studies had a 
critical risk of bias.
Discussion 
Community-based active case-finding programmes for 
tuberculosis are some of the most widely implemented 
and longest-running screening interventions ever deliv-
ered. However, their effect on tuberculosis epidemiology 
remains uncertain. In this systematic review, we aimed to 
synthesise evidence from evaluations of community-based 
tuberculosis active case-finding interventions to determine 
whether active case-finding affects tuber culo sis epidemi-
ology in communities. The review included 36 studies 
from 16 countries, comprising at least 110 million person 
years of follow-up in studies done between 1980 and 2020. 
Our main findings were that there is mixed evidence 
that active case-finding is effective at initially increasing 
tuberculosis detection when measured by case notification 
rates, and that active case-finding could reduce community 
prevalence of tuber culosis if delivered with sufficient 
intensity and coverage.
Active case-finding interventions aim to screen, diag-
nose, and link to treatment people who have asymptomatic 
or symptomatic tuberculosis disease and who have, for 
whatever reason, not been diagnosed through facility-
based services. Of note, a single round of active case-
finding, no matter how well implemented, will not have a 
last ing epidemiological effect. If active case-finding is 
implemented with sufficient intensity and over a suffi-
ciently long period or in repeated rounds, we anticipate 
that the community tuberculosis transmission would be 
reduced. The intensity of interventions will depend on 
how many people in the target population are reached, 
how often people are reached and what diagnostic 
algorithm is used (eg, who is eligible for sputum-based 
tests). Although a rapid effect on undiagnosed tuberculosis 
disease prevalence is possible, subsequent epidemiological 
effects might accumulate over several years. In the absence 
of a test of recent infection that could be used to directly 
measure the effect of active case-finding on tuberculosis 
transmission, the effectiveness of active case-finding 
interventions must be measured through indicators such 
as case notification rates, tuberculosis disease prevalence, 
and through measures of community transmission, 
including tuberculin skin test and inter feron γ release 
assay surveys among children of preschool age and 
schoolchildren. Analysis of the percen tage of cases that are 
clustered through genomic data holds promise as a 
measure of changing community tuber culosis epidemi-
ology, but it relies on high coverage of tuberculosis culture 
positivity and has not been widely used to date.
Summarising data for the effectiveness of active case-
finding on tuberculosis case notification rates, we found 
that there is inconsistent evidence from a small number 
of high-quality studies to suggest that community-based 
tuberculosis screening delivered from active case-finding 
interventions might initially increase tuberculosis case 
notification rates. In four randomised controlled trials 
that compared an active case-finding intervention to a 
non-active case-finding comparison, two showed non-
statistically significant initial increases in tuberculosis 
case notifications (in urban Brazil and rural Ethiopia), and 
two showed an increase that reached statistical significance 
(in rural Ethiopia and prisons in Ethiopia). In a further 
Country, 
population




Control population Adjusted analysis
Ayles et al 
(2010)36








Sputum smear if 
symptoms for ACF; 
culture for all for 
prevalence survey
Schoolchildren evaluated 
had TST in 2005 (before 
ACF) and same children 
had TST in 2009 
(after ACF)
391 (7·9% of 
4934 children who 
were TST-negative at 
baseline had >15 mm 
TST induration at 
endline; geometric 
mean per cluster 
incidence of TST 
conversion was 1·41 per 
100 000 person-years
342 (6·6%) of 
5169 children who were 
TST-negative at baseline 
had >15 mm TST 
induration at endline; 
geometric mean per 
cluster incidence of TST 
conversion was 1·05 per 
100 000 person-years
Adjusted rate ratio for 
incidence of 
tuberculosis infection: 
1·36 (95% CI 
0·59–3·14)




Door to door Sputum Xpert 
regardless of symptoms 
(ACF and prevalence 
survey)
Prevalence of positive 
IGRA among children born 
in 2012 (who would have 
been 1–2 years old when 
intervention started)*
23 (3·3%) of 
701 children were 
IGRA-positive
18 (2·6%) of 705 children 
were IGRA-positive
Prevalence ratio 1·29 
(95% CI 0·70–2·36)*
None of the studies had any co-interventions. ACF=active case=finding. TST=tuberculin skin test. IGRA=interferon γ release assay. *The study also included a post-hoc infection outcome of IGRA positivity among 
children born between 2004 and 2011 (who would have been 3–10 years old when intervention started); the IGRA positive prevalence ratio for intervention vs control clusters for these older children was 0·50 
(95% CI 0·32–0·78).
Table 6: Cluster-randomised trials evaluating effect of ACF on tuberculosis infection incidence or prevalence in children
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22 non-randomised studies with a wide range of designs 
and interventions assessed, data with low quality of 
evidence suggested that community-based active case-
finding might increase case notification rates. The wide 
range of study designs and interventions evaluated, 
limited reporting of data within many studies, and the 
high percentage of studies classified as being at serious or 
critical risk of bias meant that only cautious conclusions 
should be drawn from these studies. Furthermore, we do 
not have information on the costs or opportunity costs of 
active case-finding compared to other approaches that 
could be undertaken to detect tuberculosis.
We identified two cluster-randomised trials that had 
varying results on the effects of active case-finding on 
prevalence of tuberculosis disease and incidence of infec-
tion in children. The more intensively delivered door-to-
door active case-finding intervention of ACT3 in Vietnam,37 
which used a screening strategy compris ing Xpert for all, 
regardless of symptoms, reported a statistically signi ficant 
relative reduction in the prevalence of micro biologically 
confirmed tuberculosis of 45%. By contrast, the less 
intensive enhanced case-finding interven tion in the 
ZAMSTAR trial in Zambia and South Africa,36 which used 
a symptom-based and sputum smear-based screening 
approach, did not show an effect. The before-after 
evaluation that pooled data from both intervention groups 
of the DETECTB trial in Zimbabwe,11 in which active 
case-finding was delivered through moderate intensity 
interventions (mobile vans and door-to-door symptom-
based and smear-based screening), showed a relative 
reduction in culture-confirmed tuberculosis of 41%. Other 
non-randomised studies had incon sistent and imprecise 
results, and they were at critical risk of bias due to 
confounding by secular trends and selection of participants 
for inclusion and measurement of effective ness. Evi -
dence for reduced tuberculosis transmission was lacking, 
with two studies (ZAMSTAR and ACT3) reporting no 
significant difference in childhood tuberculosis infection 
(according to prespecified analyses in each study).
The effects of active case-finding for tuberculosis 
are likely to be highly context-dependent, varying with 
tuberculosis prevalence, built environment, access to 
health care, and social norms, among other factors. There 
are many possible reasons why ZAMSTAR and ACT3, 
which were done nearly 10 years apart and in different 
continents, showed differing results. ZAMSTAR used a 
less intensive case-finding approach with the aim of 
enabling community members to identify tuber culosis 
symptoms themselves and improving access to sputum 
diagnostics for tuberculosis. By contrast, ACT3 used more 
intensive screening, involving enumeration of community 
members and door-to-door tracing of all community 
members to request sputum, regardless of symptoms. 
Whether the reduction in tuberculo sis prevalence in 
ACT3 (which was not seen in ZAMSTAR) was due to the 
more intensive nature of screening in ACT3 or due to 
other context-specific factors is not known.
None of ZAMSTAR, ACT3, or DETECTB report directly 
on harms related to tuberculosis screening. In ACT3, the 
estimated positive predictive value for a positive Xpert 
result to detect a true case of tuberculosis disease in the 
context of community-wide screening was between 61% 
and 84%, depending on the reference standard that 
was applied. It is not known whether any individuals 
experienced harm (such as anxiety, unnecessary further 
investigations, or unnecessary tuberculosis treatment) as 
a result of false positive Xpert tests. We would expect that 
an intervention in which people identify their own 
symptoms and sputum diagnostics are readily and easily 
available to these people, such as that used in ZAMSTAR 
or DETECTB, would be less likely to cause individual 
harm from false positive results than an approach in 
which all individuals have sputum tests, such as in ACT3, 
because presumably the pre-test probability of tuberculosis 
is higher in those who choose to submit sputum than the 
rest of the community; however, no data are available that 
directly address this hypothesis. The resource implications 
in terms of cost and laboratory capacity are likely to be 
higher for the approach used in ACT3 compared with 
that used in ZAMSTAR, although in practice sputum 
submission during ACT3 was substantially below the 
universal target. Lastly, it is important to explore popula-
tion values and preferences around acceptability of various 
community-based tuberculosis screening approaches, 
acknowledging that this is likely to vary substantially 
between communities and countries.
This systematic review had several limitations. 
We included only manuscripts published in English. We 
reviewed the full text of 988 published manuscripts drawn 
from more than 25 000 titles and abstracts, but we did not 
include unpublished data or grey literature. Publication 
bias is possible; we are aware of several active case-
findings evaluations which are not published (eg, from 
TB REACH-funded projects). Studies generally did not 
distinguish between the number of people diagnosed 
with tuberculosis and the number started on tuberculosis 
treatment (ie, they did not account for pretreatment loss 
to follow-up). We did not assess individual-level effects of 
active case-finding, such as whether people with tuber-
culosis detected through active case-finding had less 
extensive or severe disease or better outcomes than those 
with tuberculosis detected through usual care-seeking.
We recognise that community-based studies that set out 
to evaluate active case-finding interventions are expensive, 
logistically challenging, and require very large sample 
sizes and long follow-up periods, as well as careful 
analysis to minimise bias and allow valid inference to be 
drawn. Given these challenges, we strongly recommend 
that future evaluations of the impact of active case-finding 
on tuberculosis case notification rates (which provide an 
important source of evidence under programmatic con-
ditions) are carefully designed to minimise selection 
and ascertainment bias, have prespecified protocols and 
analy sis plans, and undertake appropriate statistical 
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analy sis to adjust for confounding and the effects of tem-
poral trends with effect estimates and measures of 
uncertainty appropriately adjusted for clustering.
Tuberculosis active case-finding interventions are 
necessarily highly context-dependent. Different methods 
of delivering tuberculosis active case-finding and different 
diagnostic algorithms (eg, initial screening using symp-
tom interview vs using chest x-ray) might be used in 
different settings, depending on factors such as resources 
available, physical geography, health systems capacity, 
expected prevalence of tuberculosis (ie, pre-test probability 
of tuberculosis), prevalence of drug resistant tuberculosis, 
prevalence of HIV, and laboratory infrastructure and 
capacity. In areas with high HIV prevalence, Xpert 
MTB/Rif might be a more appropriate diagnostic test 
than sputum smear,44 and false negatives from symptom 
screening might be expected to be more common.45 Future 
studies should describe their context and inter vention in 
as much detail as possible and fully report all numerators 
and denominators for total population targeted, number of 
individuals screened, number requiring a diagnostic test, 
number receiving a diagnostic test, number testing posi-
tive, and number starting treat ment. When appropriate, 
false positive results should also be reported.
In conclusion, we found evidence to suggest that 
community-based active case-finding for tuberculosis 
might be effective in changing tuberculosis epidemiology 
if delivered with high coverage and intensity. The evidence 
for effectiveness in other settings and using alternative 
tuberculosis screening approaches was mixed. Policy 
makers should consider implementing intensive active 
case-finding interventions in urban populations with a 
high prevalence of undiagnosed tuber culosis, and in other 
populations as part of well designed research protocols to 
contribute evidence to important knowledge gaps.
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